Dataset Open Access

The process of HDAC11 Assay Development: Effect of reducing agent

Abbey, Megha; Vedadi, Masoud

An effect of adding reducing agent on the HDAC11 activity was monitored.

The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files (94.1 kB)
Name Size
3july2018-HDAC11-reducing agent.pdf
94.1 kB Download
All versions This version
Views 9797
Downloads 2525
Data volume 2.4 MB2.4 MB
Unique views 7979
Unique downloads 2424


Cite as